Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Last Updated: March 22, 2023

Actavis Labs Fl Inc Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for ACTAVIS LABS FL INC, and what generic and branded alternatives to ACTAVIS LABS FL INC drugs are available?

ACTAVIS LABS FL INC has sixty-eight approved drugs.

There are six tentative approvals on ACTAVIS LABS FL INC drugs.

Summary for Actavis Labs Fl Inc

US Patents:	0
Tradenames:	56
Ingredients:	54
NDAs:	68

Drugs and US Patents for Actavis Labs Fl Inc

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Actavis Labs Fl Inc	HYDROMORPHONE HYDROCHLORIDE	hydromorphone hydrochloride	TABLET, EXTENDED RELEASE;ORAL	202144-004	Jun 30, 2016		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Actavis Labs Fl Inc	NITROFURANTOIN	nitrofurantoin, macrocrystalline	CAPSULE;ORAL	091095-003	Jun 18, 2015	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Actavis Labs Fl Inc	CYCLOBENZAPRINE HYDROCHLORIDE	cyclobenzaprine hydrochloride	TABLET;ORAL	071611-001	May 3, 1989	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Actavis Labs Fl Inc	QUINAPRIL HYDROCHLORIDE	quinapril hydrochloride	TABLET;ORAL	076049-002	Jan 14, 2005		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Actavis Labs Fl Inc	LACOSAMIDE	lacosamide	TABLET;ORAL	204855-001	Jan 5, 2023	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for ACTAVIS LABS FL INC drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter

McKesson

McKinsey

Medtronic

Boehringer Ingelheim

Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.